Skip to main content

Advertisement

Log in

Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases

  • Clinical study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

About half of the patients with paraneoplastic diseases develop an immune response against neuronal antigens expressed by both the tumor and the nervous system. In 31 patients with anti-Hu antibodies and 19 patients with anti-Yo antibodies, we searched for the presence of additional non-neuronal auto-antibodies and further studied whether the presence of such auto-antibodies was correlated with a specific oncological or neurological presentation. Positive antinuclear antibodies (ANA) were found at a titer of 1:40 or above in 48% patients with anti-Hu antibodies, and in 37% patients with anti-Yo antibodies. Anti-cytoplasmic antibodies were also detected in 42% patients with anti-Yo antibodies. No specific correlation between the presence of non-neuronal auto-antibodies and clinical characteristics of the patients could be identified. In particular, neither the type of underlying cancer, the overall survival, the tumor response to treatment, nor the neurological presentation were related to the serological status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • JB Posner JO Dalmau (2000) ArticleTitleParaneoplastic syndromes of the nervous system Clin Chem Lab Med 38 117–122

    Google Scholar 

  • AF Carpentier B Chassande Z Amoura B Benyahia JC Piette JY Delattre (2001) ArticleTitleSystemic lupus erythematosus with anti-Hu antibodies and polyradiculoneuropathy Neurology 57 558–559

    Google Scholar 

  • EM Tan TE Feltkamp JS Smolen B Butcher R Dawkins MJ Fritzler T Gordon JA Hardin JR Kalden RG Lahita RN Maini JS McDougal NF Rothfield RJ Smeenk Y Takasaki A Wiik MR Wilson JA Koziol (1997) ArticleTitleRange of antinuclear antibodies in ‘healthy’ individuals Arthritis Rheum 40 1601–1611

    Google Scholar 

  • JW Moll H Hooijkaas BC Goorbergh Particlevan LG Roos SC Henzen-Logmans CJ Vecht (1996) ArticleTitleSystemic and anti-neuronal auto-antibodies in patients with paraneoplastic neurological disease J Neurol 243 51–56

    Google Scholar 

  • PA Silburn JC Neil SK Khoo B Daunter R Hill RJ Collins EV Mackay (1984) ArticleTitleImmune complexes in ovarian cancer: Association between IgM class complexes and antinuclear autoantibodies in ascitic fluid Int Arch Allergy Appl Immunol 174 63–66

    Google Scholar 

  • F Fernandez-Madrid PJ Vord ParticleVan de X Yang RL Karvonen PM Simpson MJ Kraut JL Granda JE Tomkiel (1999) ArticleTitleAntinuclear antibodies as potential markers of lung cancer Clin Cancer Res 5 1393–1400

    Google Scholar 

  • B Benyahia Z Amoura A Rousseau C Clanche ParticleLe A Carpentier JC Piette JY Delattre (2003) ArticleTitleParaneoplastic antineuronal antibodies in patients with systemic autoimmune diseases J Neurooncol 62 349–351

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antoine F. Carpentier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aguirre-Cruz, L., Charuel, JL., Carpentier, A.F. et al. Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases. J Neurooncol 71, 39–41 (2005). https://doi.org/10.1007/s11060-004-4536-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-004-4536-3

Keywords

Navigation